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ABSTRACT 
In this study the antibiotic susceptibility of 51 P.aeruginosa strains isolated from clinical samples were detected by the 
disc diffusion test. The susceptibility of P. aeruginosa strains were found as respectively 55% amicacin, 43% 
aztreonam, 75% netilmycin, 68% sefepim, 73% ceftazidim,  76% ciproflaxacin, 37% gentamicin, 84% meropenem, 
76% piperasillin/tazobactam, 47% tobramycin and 84% imipenem. These results show that carbapenems are the most 
effective antibiotics for P. aeruginosa strains and the efficacy of meropenem and imipenem are high for P. aeruginosa 
strains Molecular typing profiles of 43 P. aeruginosa strains which are sensitive to meropenem and imipenem 
antibiotics with AP 1 primary were determined in AP-PCR.  As a result of AP-PCR molecular typing study of this 43 P. 
aeruginosa isolate, no correlation was found out between antibiotic sensitivities and molecular types. This situation 




As well as most of the Pseudomonases (pyocyanic) 
infect people, some among them form temporizer 
pathogen which is important especially for people 
having weak immunity system. In particular, P. 
aeruginosa known as temporizer pathogen has such 
an important place among Pseudomonases.It is 
realized that infections caused by P. aeruginosa in 
humans increase in hospital ambient lately. It is also 
observed that these bacterias shelter very easily and 
their resistance increases in hospital ambient. 
Generally, treatment of Pseudomonas infections is 
ratherly slow and difficult because of this bacteria is 
resistant to frequently used antibiotics. (1, 2, 3) 
Therefore, multiple antibiotic usage is 
recommended for treatment of     P. aeruginosa 
(4,5). Particularly, in P. aeruginosa infections, the 
carbapenems are frequently used antibiotics in 
treatment. The reason why carbapenems are 
preferred in treatment is that they have wider 
influence spectrums than beta-lactam antibiotics. 
Furthermore, carbapenems are enounced as stabile 
against plasmid and also chromosomal 
betalactamases in different researches (6,7). 
Important infections caused by Pseudomonases are 
lung infections, respiratory infections, bacteriemia, 
articulation infections, urinary tract infections, 
gastrointestinal tract infections, burn and trauma 
infections, epidermic and soft tissue infections (8)  
 
In study, AP-PCR technic was used to determine 
molecular typing profiles of 43                    P. 
aeruginosa isolate that is sensitive to carbapenems. 
AP-PCR technic is frequently used in molecular 
typing of P. aeruginosa isolates which are isolated 
from clinical samples.  (9).  
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MATERIALS AND METHODS  
Obtaining samples: In study, 51 P. aeruginosa 
isolate, which was isolated from different samples 
belong to impatient in several clinics, was used. 
 
Bacteria identification: API 20 NE (BioMeriux, 
Marcy l'Etoile, France) kit was used in identification 
of bacterias (10).  
 
Antibiotic sensitivity test: In accordance with 
NCCSL standards, antibiotic sensitivity test was 
studied in Mueller-Hinton Agar with the method of 
standard disc diffusion. In disc diffusion test, 
amicasin 30 µg, aztreonam 30 µg, netilmicin 30 µg, 
sephepim 30 µg, ceftasidime 30 µg, ciproflaxacin 5 
µg, gentamicin 10 µg, meropenem 10 µg, 
piperacillin/ tazobactam 110 µg, tobramycine 10 µg 
and imipenem 10 µg (Oxoid-England) antibiotics 
were used. In research, P. aeruginosa ATCC 27853 
was used as control element (11). As a result of this 
test, sensitive P. aeruginosa isolates were chosen. 
 
DNA isolation: Isolation of 51 P. aeruginosa 
isolate was performed by phenol-chloroform 
technic (12, 13) 
 
AP-PCR Amplification: For AP-PCR reaction, 
API “5 – GTT GCG ATC -3” (Bio Thesis, 
Germany) primary was used. Each, including 100 µl 
reaction compound, was respectively calculated and 
put into 0,5 ml ependorph tubes.10 x Tampon 
(NH4)2 SO4) (Promega,USA) 10 µl, dATP, dCTP, 
dGTP, dTTP (Fermantes,Lithuania) 2 mM, Primary 
Ap 1 (Bio Thesis, Germany) 50 pmol, MgCl2 
(Fermantes,Lithuania) 25 mM, Taq DNA 
polymerase (Promega, USA) 1U and deionized 
water were added to compound to fullfil volume. 
AP-PCR reaction was performed in automatic PCR 
device (Techne,USA) under circumstances 
like:following denaturation for 5 minutes at 94°C, 
denaturation for 1 minute at 94°C making 40 cycles, 
adhesion for 2 minutes at 72°C and following last 
elongation for 6 minutes at 72°C, PCR  products 
were kept at +4°C until extrapolation. Obtained 
PCR products were conducted in % 12 
polyacrilamid gel electrophoresis (PAGE) (20 cm x 
20 cm) (Owl Scientific, USA ), 120 volts, 80 mA 
and 10 watts. PAG was painted by silver painting 
technic later on. 
 
Distributions of 51 P. aeruginosa isolates utilized in 
study as per the clinical samples are shown in Table 
1. 
Table 1. The distribution of isolators obtained from 
patient materials with respect to clinical samples  
 
Clinical samples P. aeruginosa 
Blood 15 
Sputum   6 
Aspirate 10 
Urine 12 
Wound   8 
Total 51 
 
Sensitivities of P. aeruginosa isolates to different 
antibiotics by the method of disc diffusion are 






Table 2. Sensitivity proportions of isolated P.aeruginosa to tested antibiotics with disc diffusion     methods 
 
 






















   
   
























Aztreonam 22 43 9 18 20 39 


















Ciprofloxacin 39 76 4 8 8 16 
Gentamicin 19 37 14 28 18 35 
Meropenem 43 84 1 2 7 14 
Piperasillin/tazobaktam 39 76 3 6 9 18 
Tobramycin 24 47 8 16 19 37 
Ýmipenem 43 84 3 6 5 10 
 
 
In study, 43 of 51 P. aeruginosa isolate were found out sensitive to carbapenems. Sensitivity to imipenem and 
meropenem from these antibiotics was determined as % 84. Distributions of isolates as per the samples are shown 
in Table 3. Molecular typing profiles of 43. P. aeruginosa which is sensitive to meropenem and imipenem 
antibiotics with AP 1 primary were determined in AP-PCR (picture 1a and picture 1b). In study, genotypic 
proximity was determined in number 3,4 and 5 P. aeruginosa isolates (picture 1a). In study, no common 
genotypic profile was found out among left 40 P. aeruginosa isolates sensitive to meropenem and imipenem 
(picture 1a and picture 1b). Besides, a dominant genotypic pattern was not determined among sensitive isolates. 
Table 3.  43 P. aeruginosa isolates sensitive proportions of meropenem and imipenem antibiotics  
 
  Imipenem   Meropenem  
Clinical samples D AD R D AD R 
Blood 13 1 2 12 1 3 
Sputum 5 - - 5 - - 
Aspirate 9 1 - 10 - - 
Urine 10 1 1 10 - 2 
Wound 6 - 2 6 - 2 
TOTAL 43 3 5 43 1 8 
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Figure 1a. P. aeruginosa isolates sensitive to meropenem and imipenem with AP1 primer were   determined in 
AP-PCR 
1    2   3   4   5   6    7   8   9   10  11 12 13 14 15 16 17 18  M 
                 
M: molecular size indicator [ÖX174 HaeIII cut (Fermentas, Lituanya) genotypic proximity was determined in 
number 3,4 and 5 P. aeruginosa isolates 
Figure 1b. P. aeruginosa isolates sensitive to meropenem and imipenem with AP1 primer were  determined in 
AP-PCR 
                 M  19  20  21  22 23  24  25  26  27  28   29 30  31  32  33  34  35   36 
                
               M: molecular size indicator [ÖX174 HaeIII cut (Fermentas, Lituanya)]   
 
DISCUSSION 
More than one antibiotic are used in treatment of 
infections coused by P. aeruginosa Especially in 
treatment, aminoglycosides, cephalosporins, 
carbapenems and betalactam/betalactamases 
inhibitored antipseudomonal penicillin combinations 
are preferred for the reason of ease-of-use (14).  For 
this reason, in accordance with antibiotic sensitivity 
results, 43 P. aeruginosa isolate determined as 
sensitive to  carbapenems was chosen in research. 
Sensitivities to imipenem and meropenem from  
carbapenem antibiotics are determined as % 84. As 
a result of AP-PCR molecular typing study of this 
43 P. aeruginosa isolate, no correlation was found 
out between antibiotic sensitivities and molecular 
types. In the result of the study, imipenem and 
meropenem usage can be recommended in 
P.aeruginosa infection treatment. Because, 
carbapenems used in treatment are separated than 
other betalactam antibiotics with their wider 
influence spectrum and strong antibacterial 
influences. Furthermore, carbapenems are more 
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